DR. HELMUT M. SCHUEHSLER

Chairman, TVM Capital Group – CEO,TVM Capital Healthcare Partners

Dr. Schuehsler has dedicated his career to exploring new horizons as an investor, pursuing innovation and building teams and businesses, sometimes from scratch, sometimes in new regions, and always in healthcare and with an eye on products or services that address unmet medical needs and promote societal progress. In the process he has gained extensive operating and investment experience in numerous geographies, such as Germany, the UK, France and several other European countries, the United States, the UAE and India.

On the emerging market private equity side, he currently serves as chairman of Manzil Home Health Services (Abu Dhabi) and Bourn Hall International (Dubai/Delhi) and is a board member of Ameco Medical Industries (Cairo) and Cambridge Medical & Rehabilitation Center (Abu Dhabi/Al Ain). He previously held the position of chairman at ProVita International Medical Center. On the life science side, he is currently a board member of bispecific antibody focused F-Star Group of Companies (Vienna/Cambridge, UK) and anti-infectives company, Biovertis AG (Vienna/Munich).

During his tenure with TVM Capital, Dr. Schuehsler has raised more than $1 billion in committed capital for life science and healthcare investments from global investors and has led or overseen around 100 investments in the sector. Over the years, the firm expanded from Germany to a pan-European footprint, on to the United States, the Middle East, India, Canada, and finally Southeast Asia. Over 40 TVM Capital portfolio companies in the sector went public in the United States or Europe.

1990

.
..

2003 – 2009

.

He started his investment management career at Horizonte Venture Management in Vienna, Austria, and joined TVM Capital in Munich . Since then his investment track record includes close to 30 direct investments, as well as positions as chairman, vice chairman or director at around 30 innovative life science and healthcare companies in several geographies.

As a long-time director of Max Planck Innovation, he contributed to the translation of leading German science into commercial projects. He represented the European private equity and venture capital industry at the European level in Brussels in various roles such as chairman of the Professional Standards Committee and finally in 2007/08 as chairman of the European Private Equity and Venture Capital Association (“EVCA”, now called “Invest Europe”).

1990

He started his investment management career at Horizonte Venture Management in Vienna, Austria, and joined TVM Capital in Munich . Since then his investment track record includes close to 30 direct investments, as well as positions as chairman, vice chairman or director at around 30 innovative life science and healthcare companies in several geographies.

2003 – 2009

As a long-time director of Max Planck Innovation, he contributed to the translation of leading German science into commercial projects. He represented the European private equity and venture capital industry at the European level in Brussels in various roles such as chairman of the Professional Standards Committee and finally in 2007/08 as chairman of the European Private Equity and Venture Capital Association (“EVCA”, now called “Invest Europe”).